Tretinoin and Sleep Architecture: What the Evidence Actually Shows

Does topical tretinoin affect sleep architecture?

Sleep architecture means the non-REM and REM stages measured with polysomnography. The Renova label says the adverse reactions seen in its double-blind, vehicle-controlled studies were limited primarily to the skin [1]. Its 24-week trials assessed wrinkling, pigmentation, roughness and laxity, not sleep [1].

What does the Renova label report?

The label discussed here is Renova 0.02% cream, not every tretinoin product. It is an adjunct, with skin care and sun avoidance, for fine facial wrinkles [1]. Almost all patients reported one or more local reactions: peeling, dry skin, burning, stinging, erythema and pruritus [1]. In 32% of study patients, irritation was severe, led to temporary discontinuation or led to a mild topical corticosteroid; about 4% discontinued for adverse reactions [1].

How much tretinoin is absorbed?

The label says absorption from various topical formulations ranged from 1% to 31% of the applied dose, depending on healthy versus dermatitic skin [1]. For a 0.05% oil-in-water cream, less than 2% was absorbed in seven healthy men after one application and in seven after 28 daily applications. Bioavailability was lower after repeated use, and endogenous tretinoin concentrations did not differ significantly [1]. No percutaneous absorption study was done with Renova 0.02% in human volunteers [1].

When does the label say to apply tretinoin?

The Renova label directs once-daily evening application [1]. It separately advises avoiding or minimizing sun exposure and using sunscreen (minimum SPF 15) and protective clothing [1]. Its warnings cover photosensitizing drugs, sunlight and local irritation, and its dosage section says not to use it in patients who are pregnant or attempting to become pregnant [1].

Is topical tretinoin the same as oral isotretinoin?

No. Oral isotretinoin is a different drug product, taken as a capsule, with a boxed warning and the iPLEDGE REMS. None of the 52 single-ingredient topical tretinoin labels in openFDA, including Renova, carries a boxed warning.